Impact of ILD-specific therapies on perioperative course in patients with progressive fibrosing ILD undergoing lung transplantation

Immunosuppressants and antifibrotics have shown consistent effects on lung function decline in several ILD diseases, opening the door for combined antifibrotic and immunosuppressant drug therapy. The aim of this retrospective study was to evaluate the potential effects of different treatment regimen on perioperative course in patients with PF-ILD undergoing LTx.